Date | Market Capitalization | Share Price | Price to Earnings Ratio (P/E) | Price to Sales Ratio (P/S) |
---|
CEO | Dr. Thomas Schinecker |
IPO Date | Aug. 3, 1995 |
Location | Switzerland |
Headquarters | Konzern Hauptsitz |
Employees | 103,605 |
Sector | Health Care |
Industries |
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.
Past 5 years
USD 98.09
USD 629.14
USD 137.45
USD 607.04
USD 116.68
StockViz Staff
October 16, 2024
Any question? Send us an email